Environmental Impact Statements; Availability, etc.: Proposed Sunrise[...]
Withdrawal of Approval of Drug Application: SpecGX LLC et al.
01/09/2022 | Press release | Distributed by Public on 01/10/2022 02:31
Please select the service you want to use:
Smartlinks | IM Cannabis Corp. | News | Health | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Financial Services | Pharmaceuticals | Public Companies | Alternative Medicine Companies | Canadian Securities Exchange (CSE) | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Aequitas NEO Exchange | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | OmegaATS | Lynx ATS | Nasdaq CXC | Nasdaq CX2 | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact